Skip to main content

Table 2 Feasibility of implementing HIIT in breast cancer patients undergoing anthracycline chemotherapy

From: Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial

  HIIT group (n = 15) CON group (n = 15)
Recruitment rate, % 51.7
Retention rate, % 100 100
Adherence to HIIT, % 82.3 N/A
Minutes of HIIT per week, mean (SD) 78 ± 5.1 min N/A
Number of HIIT sessions per each cycle of chemotherapy cycle, mean (SD)
 1st cycle 2.79 ± 0.58 N/A
 2nd cycle 2.64 ± 0.93
 3rd cycle 2.21 ± 1.10
 4th cycle 1.29 ± 1.38
  1. Note. Data are presented as % unless otherwise indicated. No significant baseline differences between groups were observed (p > 0.05) Abbreviations: BMI body mass index, HIIT high intensity interval training, CON non-exercise control, SD standard deviation